List of Tables
Table 1. Global Skin Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Skin Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Skin Cancer Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Skin Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Skin Cancer Molecular Diagnostics Market Share by Region (2020-2025)
Table 10. Global Skin Cancer Molecular Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Skin Cancer Molecular Diagnostics Market Share by Region (2026-2031)
Table 12. Skin Cancer Molecular Diagnostics Market Trends
Table 13. Skin Cancer Molecular Diagnostics Market Drivers
Table 14. Skin Cancer Molecular Diagnostics Market Challenges
Table 15. Skin Cancer Molecular Diagnostics Market Restraints
Table 16. Global Skin Cancer Molecular Diagnostics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Skin Cancer Molecular Diagnostics Market Share by Players (2020-2025)
Table 18. Global Top Skin Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Cancer Molecular Diagnostics as of 2024)
Table 19. Ranking of Global Top Skin Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Skin Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Skin Cancer Molecular Diagnostics, Headquarters and Area Served
Table 22. Global Key Players of Skin Cancer Molecular Diagnostics, Product and Application
Table 23. Global Key Players of Skin Cancer Molecular Diagnostics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Skin Cancer Molecular Diagnostics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Skin Cancer Molecular Diagnostics Revenue Market Share by Type (2020-2025)
Table 27. Global Skin Cancer Molecular Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Skin Cancer Molecular Diagnostics Revenue Market Share by Type (2026-2031)
Table 29. Global Skin Cancer Molecular Diagnostics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Skin Cancer Molecular Diagnostics Revenue Market Share by Application (2020-2025)
Table 31. Global Skin Cancer Molecular Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Skin Cancer Molecular Diagnostics Revenue Market Share by Application (2026-2031)
Table 33. North America Skin Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Skin Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Skin Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Skin Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Skin Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Skin Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Skin Cancer Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Skin Cancer Molecular Diagnostics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Skin Cancer Molecular Diagnostics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Skin Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Skin Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Skin Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Skin Cancer Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Skin Cancer Molecular Diagnostics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Skin Cancer Molecular Diagnostics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Inmedi Company Details
Table 49. Inmedi Business Overview
Table 50. Inmedi Skin Cancer Molecular Diagnostics Product
Table 51. Inmedi Revenue in Skin Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 52. Inmedi Recent Development
Table 53. Roche Company Details
Table 54. Roche Business Overview
Table 55. Roche Skin Cancer Molecular Diagnostics Product
Table 56. Roche Revenue in Skin Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 57. Roche Recent Development
Table 58. Annoroad Company Details
Table 59. Annoroad Business Overview
Table 60. Annoroad Skin Cancer Molecular Diagnostics Product
Table 61. Annoroad Revenue in Skin Cancer Molecular Diagnostics Business (2020-2025) & (US$ Million)
Table 62. Annoroad Recent Development
Table 63. Research Programs/Design for This Report
Table 64. Key Data Information from Secondary Sources
Table 65. Key Data Information from Primary Sources
Table 66. Authors List of This Report
List of Figures
Figure 1. Skin Cancer Molecular Diagnostics Picture
Figure 2. Global Skin Cancer Molecular Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Skin Cancer Molecular Diagnostics Market Share by Type: 2024 VS 2031
Figure 4. PCR Features
Figure 5. FISH Features
Figure 6. DNA Sequencing Features
Figure 7. Gene Chip Features
Figure 8. Global Skin Cancer Molecular Diagnostics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Skin Cancer Molecular Diagnostics Market Share by Application: 2024 VS 2031
Figure 10. Clinical Diagnosis Case Studies
Figure 11. Drug Screening Case Studies
Figure 12. Research Case Studies
Figure 13. Skin Cancer Molecular Diagnostics Report Years Considered
Figure 14. Global Skin Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Skin Cancer Molecular Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Skin Cancer Molecular Diagnostics Market Share by Region: 2024 VS 2031
Figure 17. Global Skin Cancer Molecular Diagnostics Market Share by Players in 2024
Figure 18. Global Top Skin Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Skin Cancer Molecular Diagnostics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Skin Cancer Molecular Diagnostics Revenue in 2024
Figure 20. North America Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Skin Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 22. United States Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Skin Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 26. Germany Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Skin Cancer Molecular Diagnostics Market Share by Region (2020-2031)
Figure 34. China Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Skin Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 42. Mexico Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Skin Cancer Molecular Diagnostics Market Share by Country (2020-2031)
Figure 46. Turkey Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Skin Cancer Molecular Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Inmedi Revenue Growth Rate in Skin Cancer Molecular Diagnostics Business (2020-2025)
Figure 50. Roche Revenue Growth Rate in Skin Cancer Molecular Diagnostics Business (2020-2025)
Figure 51. Annoroad Revenue Growth Rate in Skin Cancer Molecular Diagnostics Business (2020-2025)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed